NCT01217437 2021-07-23Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal TumorsNational Cancer Institute (NCI)Phase 2 Completed108 enrolled 14 charts
NCT00544778 2014-08-28Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone SarcomaCity of Hope Medical CenterPhase 2 Terminated7 enrolled 2 charts
NCT00276692 2013-06-26Irinotecan in Treating Patients With Newly Diagnosed Ewing's SarcomaNational Cancer Institute (NCI)Phase 2 Completed35 enrolled
NCT00004078 2013-06-14Irinotecan in Treating Children With Refractory Solid TumorsChildren's Oncology GroupPhase 2 Completed181 enrolled
NCT00101270 2013-06-05Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasNational Cancer Institute (NCI)Phase 1 Completed24 enrolled